Diagnosis and therapy for prostate cancer with Lutetium-177 PSMA–DKFZ 617
A new procedure (the Lu-177 PSMA therapy) combines exact diagnostics with efficient therapy. This opens up additional treatment options for patients with advanced prostate cancer. The preliminary costs of 1 cycle (excluding PET/CT , scintigraphy of the kidneys) are around 8.500,00 €. The detailed calculation will be provided upon request.